PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
9422083-0	1998	Inhibitory effect of amiloride on the urokinase plasminogen activators in prostatic cancer.	Amiloride	21-30	plasminogen activator, urokinase	Rattus norvegicus	38-70	
9422083-1	1998	The diuretic drug amiloride (AMLD), which competitively inhibits the catalytic activity of urokinase plasminogen activators (UPA), was used to study its effects on the proteolytic enzymes implicated in the invasiveness and metastases in a prostatic tumor model carrying two different sublines of adenocarcinoma of the prostate.	Amiloride	18-27	plasminogen activator, urokinase	Rattus norvegicus	91-123	
9422083-1	1998	The diuretic drug amiloride (AMLD), which competitively inhibits the catalytic activity of urokinase plasminogen activators (UPA), was used to study its effects on the proteolytic enzymes implicated in the invasiveness and metastases in a prostatic tumor model carrying two different sublines of adenocarcinoma of the prostate.	Amiloride	18-27	plasminogen activator, urokinase	Rattus norvegicus	125-128